SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,246.03 -352.64
( -0.48%)

Global Indices

Nasdaq

52,406.83 24.25
(0.05%)

Dow Jones

7,744.04 46.27
(0.60%)

Hang Seng

64,060.29 791.92
(1.25%)

Nikkei 225

10,685.39 -81.94
(-0.76%)

Forex

USD-INR

95.11 0.17
(0.18%)

EUR-INR

106.49 0.13
(0.12%)

GBP-INR

127.03 0.10
(0.08%)

JPY-INR

0.60 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

394.8213477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

36.06

93959.21

EPS(TTM)

Face Value()

Div & Yield %

45.29

0.25

Back

Basilic Fly Studio consolidated net profit declines 36.27% in the June 2026 quarter

Aug 15,2026

Net profit of Basilic Fly Studio declined 36.27% to Rs 6.50 crore in the quarter ended June 2026 as against Rs 10.20 crore during the previous quarter ended June 2025. Sales rose 9.87% to Rs 103.50 crore in the quarter ended June 2026 as against Rs 94.20 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	103.50	94.20	10
OPM %	13.91	19.75	-
PBDT	14.40	17.00	-15
PBT	9.10	13.70	-34
NP	6.50	10.20	-36

73,246.03 -352.64 ( -0.48%)

52,406.83 24.25 (0.05%)

7,744.04 46.27 (0.60%)

64,060.29 791.92 (1.25%)

10,685.39 -81.94 (-0.76%)

95.11 0.17 (0.18%)

106.49 0.13 (0.12%)

127.03 0.10 (0.08%)

0.60 0.00 (-0.05%)